238
Views
2
CrossRef citations to date
0
Altmetric
Case Conferences

A Four-Year-Old with History of Kawasaki Disease Presenting in Acute Shock

Pages 281-288 | Received 30 Jun 2019, Accepted 13 Mar 2020, Published online: 01 May 2020

References

  • Arkin AA, Citak A. Pediatric Shock. Signa Vitae. 2008;3(1):13–23. doi:10.22514/SV31.042008.2.
  • Wheeler DS. Pediatric Shock: An Overview. TOPEDJ. 2013;7(1):2–9. doi:10.2174/1874309901307010002.
  • De Caen AR, Berg MD, Chameides L, Gooden CK, Hickey RW, Scott HF, Sutton RM, Tijssen JA, Topjian A, van der Jagt EW, et al. Part 12: pediatric advanced life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18 Suppl 2):S526–42. doi:10.1161/CIR.0000000000000266.).
  • Seaton KK, Kharbanda A. Evidence-based management of Kawasaki disease in the emergency department. Pediatr Emerg Med Pract. 2015;12(1):1–20.
  • Gordon JB, Kahn AM, Burns JC. When Children With Kawasaki Disease Grow Up. J Am Coll Cardiol. 2009;54(21):1911–20. doi:10.1016/j.jacc.2009.04.102.
  • Shimizu C, Sood A, Lau HD, Oharaseki T, Takahashi K, Krous HF, Campman S, Burns JC. Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood. Cardiovasc Pathol. 2015;24(5):310–6. ), doi:10.1016/j.carpath.2015.02.006.
  • McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E. Diagnosis, treatment, and long-term management of kawasaki disease: A scientific statement for health professionals from the american heart association. Circul. 2017;135(17):e927–e999. doi:10.1161/CIR.0000000000000484.
  • Kuo H-C, Li S-C, Guo MM-H, Huang Y-H, Yu H-R, Huang F-C, Jiao F, Kuo H-C, Andrade J, Chan W-C, et al. Genome-Wide association study identifies novel susceptibility genes associated with coronary artery aneurysm formation in kawasaki disease. PLoS One. 2016;11(5):e0154943. doi:10.1371/journal.pone.0154943.
  • Friedman KG, Gauvreau K, Hamaoka Okamoto A, et al. Coronary artery aneurysms in kawasaki disease: Risk factors for progressive disease and adverse cardiac events in the us population. J Am Heart Assoc. 2016;5(9):e003289–19. doi:10.1161/JAHA.116.003289.
  • Denver Metropolitan Prehospital protocols. http://www.dmemsmd.org/sites/default/files/Denver%20Metro%20Protocols%20July%202016_FINAL.pdf.
  • Hu F, Shi X, Li Y, Hua Y, Zhou K. Ventricular arrhythmia as an initial sign in acute Kawasaki disease. A Case Report. Med. 2018;97(18):e0641. doi:10.1097/MD.0000000000010641.
  • Greene N, Bhananker S, Ramaiah R. Vascular access, fluid resuscitation, and blood transfusion in pediatric trauma. Int J Crit Illn Inj Sci. 2012; 2(3):135–42. doi:10.4103/2229-5151.100890.
  • Amarilyo G, Koren Y, Brik Simon D, Bar-Meir M, Bahat H, Helou MH, Mendelson A, Hezkelo N, Chodick G, Berkun Y, et al. Y. High-dose aspirin for Kawasaki disease: outdated myth or effective aid?. Clin Exp Rheumatol. 2017; 103(1):209–12.
  • Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr. 1997; 131(6):888–93. doi:10.1016/S0022-3476(97)70038-6.
  • Gamez-Gonzalez LB, Moribe-Quintero I, Cisneros-Castolo M, Varela-Ortiz J, Munoz-Ramırez M, Garrido-Garcıa M, Yamazaki-Nakashimada M. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease. Pediatr Int. 2018;60(9):781–90. doi:10.1111/ped.13614.
  • Zhang H, Xie L, Xiao T. Extracorporeal Membrane Oxygenation Support for Cardiac Dysfunction Due to Kawasaki Disease Shock Syndrome. Front Pediatr. 2019; 7(221):1–5. doi:10.3389/fped.2019.00221.
  • Taddio A, Rossi ED, Monasta L, Pastore S, Tommasini A, Lepore L, Bronzetti G, Marrani E, Mottolese BD, Simonini G, et al. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Clin Rheumatol. 2017;36(1):223–8. doi:10.1007/s10067-016-3316-8.
  • Dominguez SR, Friedman K, Seewald R, Anderson M, Willis L, Glodé MP. Kawasaki Disease in a Pediatric Intensive Care Unit: A Case-Control Study. Pediatrics. 2008; 122 (4):e786–e790. doi:10.1542/peds.2008-1275.
  • Sundel R. Kawasaki disease: Initial treatment and prognosis. In: Post TW, editor. UpToDate. Waltham, MA: UpToDate Inc.; 2020. https://www.uptodate.com (Accessed on January 02, 2020).
  • Zheng X, Yue P, Liu L, Tang C, Ma F, Zhang Y, Wang C, Duan H, Zhou K, Hua Y, et al. Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis. PLoS One. 2019;14(5):e0217274. doi:10.1371/journal.pone.0217274.
  • McKiernan CA, Lieberman SA. Circulatory Shock in Children. Pediatrics in Review. 2005; 26(12):451–60. doi:10.1542/pir.26-12-451.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.